Moody's Corporation has announced a preliminary prospectus supplement for the offering of senior notes, a significant move aimed at raising capital. This decision is crucial for the company as it seeks to strengthen its financial position and support its ongoing operations.
Moody's Corporation, a key player in the consumer credit reporting and collection agencies sector, operates under the SIC code 7320. The company is listed on the New York Stock Exchange under the ticker symbol MCO. As a large accelerated filer, Moody's has been active in the capital markets, with recent filings indicating a robust engagement with investors.
The filing, dated November 9, 2026, outlines the company's intention to offer a specified aggregate principal amount of senior notes. These notes will be senior unsecured obligations and will rank equally with all existing and future unsubordinated indebtedness. The company plans to apply for listing the notes on the New York Stock Exchange, which could provide additional liquidity for investors.
According to the filing, "We will pay interest on the notes annually in arrears," with the first payment expected in 2027. The notes will mature on a date yet to be specified, but they will include provisions for redemption prior to maturity under certain conditions. This flexibility may appeal to investors looking for secure yet adaptable investment options.
This offering could impact various stakeholders, including investors who may find new opportunities in Moody's financial instruments. Additionally, competitors in the consumer credit reporting industry may need to consider their own capital strategies in response to Moody's actions, which could lead to increased competition for investment and market share.
As for the next steps, Moody's has not specified any immediate actions following this filing. However, the company is likely to engage with potential investors and finalize the details of the offering in the coming weeks.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










